# US 2024/0002926 A1 · Method for identifying an infectious agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002926 A1
- Document ID: US20240002926A1
- Status: Published application
- Kind: A1
- Application number: 18/254,399
- Filed: 2020-11-26
- Published: 2024-01-04
- Earliest claimed: 2020-11-26
- Assignees: Institut National de la Sante et de la Recherche Medicale; Universite Paris Est Creteil Val De Marne; Assistance Publique-Hopitaux de Paris
- Applicants: Institut National De La Santé Et De La Recherche MéDicale; Universite Paris Est Creteil Val De Marne; Assistance Publique Hopitaux De Paris
- Inventors: Christophe RODRIGUEZ; Jean-Michel PAWLOTSKY; Vanessa DEMONTANT
- Web page: https://patentgrep.com/patent/US20240002926A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G16B 30/10: Sequence alignment; Homology search
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The present invention provides methods for detecting, identifying, classifying, quantifying and/or characterizing an infections agent. The invention relates to a method for detecting, identifying, classifying, quantifying and/or genetically characterizing an infections agent comprising the steps of: —providing a sample of nucleic acid sequences; —isolating high-quality nucleic acid sequences out of the sample of nucleic acid sequences; —isolating at least one non-human high quality nucleic acid sequence out of the high-quality nucleic acid sequences; —identifying a closest known sequence out of a plurality of known sequences, wherein the closest known sequence shares the highest amount of similarities with the at least one non-human high quality nucleic acid sequence among the plurality of known sequences, and wherein the plurality of known sequences comprises sequences of infectious agents.

## Claims

### Claim 1

A method for identifying an infectious agent comprising:
providing a sample of nucleic acid sequences;
isolating high-quality nucleic acid sequences out of the sample of nucleic acid sequences;
isolating at least one non-animal high-quality nucleic acid sequence out of the high-quality nucleic acid sequences; and
identifying a closest known sequence out of a plurality of known sequences, wherein the closest known sequence shares the highest amount of information with the at least one non-animal high-quality nucleic acid sequence among the plurality of known sequences, and wherein the plurality of known sequences comprises sequences of infectious agents.

### Claim 2 (depends on 1)

The method of claim 1 wherein providing a sample of nucleic acid sequences comprises extracting the nucleic acid sequences, and wherein the method further comprises monitoring extracting the nucleic acid sequences so as to generate information comprising at least one of the progress of the extraction and the origin of the sample.

### Claim 3 (depends on 1)

The method of claim 1, wherein providing a sample of nucleic acid sequences comprises providing a sample of RNA sequences.

### Claim 4 (depends on 1)

The method claim 1, wherein isolating high-quality nucleic acid sequences out of the sample of nucleic acid sequences comprises isolating sequences the quality of which is above a predetermined threshold out of the sample of nucleic acid sequences.

### Claim 5 (depends on 1)

The method claim 1, wherein the plurality of known sequences is a database.

### Claim 6 (depends on 5)

The method of claim 5, wherein the database comprises an NCBI database.

### Claim 7 (depends on 1)

The method claim 1 further comprising checking whether the amount of shared information between the closest known sequence and the at least one non-human high quality nucleic acid sequence is above a predetermined threshold.

### Claim 8

The method further comprising generating an analysis report.

### Claim 9 (depends on 1)

The method claim 1, wherein providing a sample of nucleic acid sequences comprises providing a sample of bacterial, fungal, parasite or viral RNA sequences.

### Claim 10 (depends on 1)

The method claim 1 further comprising isolating high-quality nucleic acid sequences out of a sample deprived of any nucleic acid sequences of interest.

### Claim 11

A kit for identifying an infectious agent comprising:
a sample provider configured to be provided with a sample of nucleic acid sequences,
means for implementing a method for identifying an infectious agent, and
means for displaying results based on a closest known sequence;
wherein the method for identifying an infectious agent comprises:
providing a sample of nucleic acid sequences;
isolating high-quality nucleic acid sequences out of the sample of nucleic acid sequences;
isolating at least one non-animal high-quality nucleic acid sequence out of the high-quality nucleic acid sequences; and
identifying a closest known sequence out of a plurality of known sequences, wherein the closest known sequence shares the highest amount of information with the at least one non-animal high-quality nucleic acid sequence among the plurality of known sequences, and wherein the plurality of known sequences comprises sequences of infectious agents.

### Claim 12

A computer program product comprising code configured to, when executed by a processor or an electronic control unit, performs
providing a sample of nucleic acid sequences;
isolating high-quality nucleic acid sequences out of the sample of nucleic acid sequences;
isolating at least one non-animal high-quality nucleic acid sequence out of the high-quality nucleic acid sequences; and
identifying a closest known sequence out of a plurality of known sequences, wherein the closest known sequence shares the highest amount of information with the at least one non-animal high-quality nucleic acid sequence among the plurality of known sequences, and wherein the plurality of known sequences comprises sequences of infectious agents.

### Claim 13 (depends on 1)

The method of claim 1, wherein the plurality of known sequences comprises sequences of at least one fungal discriminant gene of interest and wherein said identification indicates the infectious agent.

### Claim 14 (depends on 6)

The method of claim 6, wherein the NCBI database is an enriched NCBI database.

### Claim 15 (depends on 8)

The method of claim 8, wherein the analysis report is in a format of interest.
